We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+9.75%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$268B
AUM Growth
+$39.7B
Cap. Flow
+$21.8B
Cap. Flow %
8.14%
Top 10 Hldgs %
12.83%
Holding
12,049
New
1,180
Increased
5,214
Reduced
3,562
Closed
1,371

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$850M
2
AAPL icon
Apple
AAPL
+$778M
3
TSLA icon
Tesla
TSLA
+$569M
4
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$351M
5
JNJ icon
Johnson & Johnson
JNJ
+$336M

Sector Composition

Rank Sector Weight
1 Technology 10.83%
2 Healthcare 7.49%
3 Financials 7.15%
4 Consumer Discretionary 4.92%
5 Industrials 4.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONCT
9201
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$4.76K ﹤0.01%
238
-594
-71% -$11.8K
VIRX
9202
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.76K ﹤0.01%
3,258
+786
+32% +$2.3K
IDR icon
9203
Idaho Strategic Resources
IDR
$524M
$4.75K ﹤0.01%
834
-18,131
-96% -$102K
PSHG icon
9204
Performance Shipping
PSHG
$21.6M
$4.75K ﹤0.01%
1,341
-2,309
-63% -$9.23K
ORGNW
9205
DELISTED
Origin Materials Inc Warrants
ORGNW
$4.74K ﹤0.01%
+5,449
New +$5.65K
ATAKU
9206
DELISTED
Aurora Technology Acquisition Corp. Unit
ATAKU
$4.74K ﹤0.01%
467
FTHM icon
9207
Fathom Holdings
FTHM
$24.5M
$4.74K ﹤0.01%
1,115
-291
-21% -$1.38K
RISR icon
9208
FolioBeyond Alternative Income and Interest Rate Hedge ETF
RISR
$312M
$4.74K ﹤0.01%
+150
New +$4.7K
THLV icon
9209
THOR Low Volatility ETF
THLV
$57.2M
$4.74K ﹤0.01%
+192
New +$4.71K
RTAI
9210
Rareview Tax Advantaged Income ETF
RTAI
$17.7M
$4.73K ﹤0.01%
229
+3
+1% +$60
CHNA
9211
DELISTED
Loncar China BioPharma ETF
CHNA
$4.73K ﹤0.01%
252
-859
-77% -$14.4K
MBOT icon
9212
Microbot Medical
MBOT
$124M
$4.72K ﹤0.01%
1,567
+962
+159% +$3.99K
TSPA icon
9213
T. Rowe Price US Equity Research ETF
TSPA
$4.37B
$4.7K ﹤0.01%
207
-103
-33% -$2.37K
BGXX
9214
DELISTED
Bright Green Corporation Common Stock
BGXX
$4.7K ﹤0.01%
10,000
-3,625
-27% -$2.1K
ZFOX
9215
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
$4.69K ﹤0.01%
942
+923
+4,858% +$4.28K
TSP
9216
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$4.69K ﹤0.01%
2,859
-578
-17% -$2.06K
IVSG
9217
DELISTED
Invesco Select Growth ETF
IVSG
$4.69K ﹤0.01%
503
PCTTU
9218
PureCycle Technologies Inc Unit
PCTTU
$108M
$4.68K ﹤0.01%
516
-13
-2% -$127
ALTI icon
9219
AlTi Global
ALTI
$512M
$4.68K ﹤0.01%
429
-1,454
-77% -$14.5K
VNRX icon
9220
VolitionRx Ltd
VNRX
$9.58M
$4.68K ﹤0.01%
96
-810
-89% -$31.5K
TYGO icon
9221
Tigo Energy
TYGO
$99M
$4.67K ﹤0.01%
458
+400
+690% +$4.06K
FRBNU
9222
DELISTED
Forbion European Acquisition Corp. Unit
FRBNU
$4.66K ﹤0.01%
451
LTRPA
9223
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$4.65K ﹤0.01%
6,940
-5,509
-44% -$5.18K
APWC icon
9224
Asia Pacific Wire & Cable
APWC
$66.4M
$4.64K ﹤0.01%
3,222
-1,050
-25% -$1.36K
SNCE
9225
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.64K ﹤0.01%
+552
New +$10.8K

Similar funds

UBS Group's Q4 2022 Portfolio in Review

As of Q4 2022, UBS Group held 12,049 positions worth $268B, up 17% from $228B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group deployed $21.8B of net new capital in Q4 2022, opening 1,180 new positions and adding to 5,214 existing holdings. Its largest new stake was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 11% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Salesforce, an estimated $372M trimmed.

  • UBS Group's largest Q4 2022 buy was Avantis US Small Cap Value ETF: 210,571 shares worth $15.7M.
  • UBS Group added most to Microsoft in Q4 2022, an estimated $850M increase.
  • UBS Group's biggest Q4 2022 reduction was Salesforce, cutting an estimated $372M.
  • UBS Group fully exited Citrix Systems Inc in Q4 2022, selling an estimated $223M.
  • UBS Group's ten largest holdings make up 13% of its $268B portfolio in Q4 2022.
  • UBS Group opened 1,180 new positions and closed 1,371 in Q4 2022.
  • UBS Group's portfolio value rose 17% quarter-over-quarter to $268B.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.